Target intelligence / Profile preview

Adipogenic transcriptional program

Molecular classification
Transcription factor, Other
01

Overview

The adipogenic transcriptional program is a highly orchestrated cascade of gene expression events that transforms undifferentiated mesenchymal stem cells into mature, lipid-storing adipocytes (Rosen & MacDougald, 2006, Nature Reviews Molecular Cell Biology). This process is primarily driven by a core set of transcription factors, most notably Peroxisome Proliferator-Activated Receptor gamma (PPAR-gamma) and members of the CCAAT/enhancer-binding protein (C/EBP) family (Farmer, 2006, Genes & Development). These factors work in concert to activate the expression of thousands of genes involved in insulin sensitivity, lipid synthesis, and adipokine secretion (Lefterova & Lazar, 2009, Trends in Endocrinology & Metabolism). Dysregulation of this program is central to the development of metabolic disorders such as obesity and type 2 diabetes (Evans et al., 2004, Nature Medicine). While the program itself is a complex biological process rather than a single protein, its key components—particularly PPAR-gamma—have been successfully targeted by drugs like thiazolidinediones to improve metabolic health (Yki-Järvinen, 2004, New England Journal of Medicine).

Other names
Adipogenesis pathwayAdipocyte differentiation programTranscriptional regulation of adipogenesis
02

Mechanism of action

Activation of the master transcription factor PPAR-gamma and associated C/EBP proteins to induce the expression of genes necessary for adipocyte maturation and lipid storage (Farmer, 2006, Genes & Development; Rosen & MacDougald, 2006, Nature Reviews Molecular Cell Biology).

03

Biological functions

Cell differentiationLipid metabolismEnergy homeostasis
04

Disease associations

ObesityType 2 diabetesMetabolic syndromeLipodystrophy
05

Safety considerations

Weight gainFluid retentionBone lossCongestive heart failure risk
06

Interacting drugs

Pioglitazone

2 more in the full profile.

07

Biomarkers

Peroxisome proliferator-activated receptor gamma (PPARG)Fatty acid-binding protein 4 (FABP4)AdiponectinLeptin

Beyond the preview

Go deeper on Adipogenic transcriptional program.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipogenic transcriptional program.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call